Global Needle Free Drug Delivery Devices Market Research and Analysis 2017-2022

Global Needle Free Drug Delivery Devices Market, Size, Share, Market Intelligence, Company Profiles, Market Trends, Strategy, Analysis, Forecast 2017-2022

Needle free drug delivery devices Market insights:
Drug delivery is a crucial event in the field of human healthcare. The healthcare companies provide fast reacting chemical compounds in the form of solid pills, ointments, gel, and injections. However, for the last few decades, a new era of technology has been evolved that focuses on the development of novel methods to deliver drug with an aim to provide safety, efficacy, and compliance to the patients. This novel method involves administering of drugs into the human body without piercing the skin. This method is beneficial over traditional method of drug delivery in a number of ways. For example, drug administration via solid pills or tablets is completely non-invasive. Though it is non-invasive, it does not taste well, which propels the patients to avoid taking pills. In addition, in some cases taking pills may cause some sort of side effects that can damage the patient’s health.

Needle free injections have been adopted in routine immunization as a safe and effective delivery of vaccine. Vaccine delivery by using needles addresses a number of issues associated with the needles. For example, there are annually 800,000 needle stick injuries in the US alone, and this number is even more than the global perspective. Accidental needle stick injuries is one of the major safety issues for patients and providers as it causes about 315,000 hepatitis C, 1.7 million hepatitis B and 33,800 HIV infections. Elimination of needles from drug delivery system will eradicate needle stick injuries and will ultimately reduce these infections.

For Full Reports: https://www.omrglobal.com/industry-reports/global-needle-free-drug-delivery-market/

The needle free delivery shows significant response for any drug. For instance, Zika virus vaccine was clinically proved to show greater response with needle free drug delivery system. Since 2015, there were over 700,000 cases of Zika virus in the Americas alone. With this outbreak, the pharmaceutical companies focused on developing the vaccines against Zika virus that can be administered with needle free system. PharmaJet Stratis is a needle free injector that can be used to deliver vaccine with higher immune response. Another vaccine that can be delivered using PharmaJet Stratis is DNA vaccine that has been recently developed as a result of the collaboration between the two companies; PharmaJet and Genexine in February 2018.

Needle free technology is estimated to have tremendous opportunity during the forecast period. Drugs in the development stage needs minimally invasive way to deliver it. There is an increasing demand for better approaches of drug delivery from customers. Needle free injection systems are customizable and can be modified to optimize productivity. These drug delivery systems eliminate the risks related to the health of the customers and healthcare cost related to the infections that can be caused using traditional methods of drug delivery. In addition, it has no disposable issues. It benefits the pharmaceutical industries in increasing the sales of the products and provide improved outcomes. In the developing world, there are a number of challenges for transmission of diseases through the re-use of the same needle that can be abated by adopting needle free drug delivery systems.

Geographical Insights:
Global needle free drug delivery market is regionally segmented into North America, Europe, Asia Pacific and Rest of the world. North American region dominates the global market, this region held the largest revenue share of the global Needle Free drug delivery devices market in 2016. This can be attributed majorly due to the increasing prevalence of chronic diseases, , high awareness pertaining to novel drug delivery systems among the patient base, development of biologics and pharmaceutical drugs and devices and an increasing number of R&D investments by prominent market players domiciled in this region.

Competitive Insights:
The Key Players In The Global needle free drug delivery devices Market Include 3 M, AkraDermojetInc, Antares Pharma Inc., Bayer Ag, Bioject Medical Technologies, Inc., GlaxosmithklinPlc, Glide Pharmaceutical Technologies Ltd., InjexPharma Ag, Jdrf, Johnson & Johnson, Inc., Medtronic, Inc., Merck And Co., Nemera, Novartis Ag, PancreumLlc, Pfizer, Inc., Pharmajet, Inc., Sanofi, Tandem Diabetes Care, Inc., Zogenix, Inc. And so on Partnership, R&D, M&A, Product Launch Are the Key Strategy Adopted In The global needle free drug delivery devices Market.

Market Segmentation:
Global needle free drug delivery devices Market is segmented on the basis of technology, applications, end users and regional outlook. On the basis of technology market is divided into Oral drug delivery system, Inhaler technology, Laser based needle free injectors, Jet injectors, Novel needle free technologies, spring based needle free injectors, Transdermal patch technology and other needle free technology. The Jet injectors is having the largest market share and is dominating the technology segment in 2016, majorly due to its high usage rate and extensive applicability in delivering a large range of drugs.

OMR Report covers:
• Comprehensive research methodology of Global needle free drug delivery devices Market.
• This report also includes detailed and extensive market overview with key analyst insights.
• Exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
• Analysis of regional regulations and other government policies impacting the Global needle free drug delivery devices Market.
• Insights about market determinants which are stimulating the Global needle free drug delivery devices Market.
• Detailed and extensive market segments with regional distribution of forecasted revenues.
• Extensive profiles and recent developments of market players.

The global pharmaceuticals revenue has reached over one trillion USD and expected to grow across the globe. North America is predicted to contribute more than 40 percent of the total market revenues followed by Europe. Product launch, partnership, Mergers & Acquisitions are the key strategies adopted by the pharmaceutical giants to stay competitive. The market is expected to grow significantly due to global rise in life style oriented diseases, huge investment in research and development and huge opportunity created by emerging economies. Additionally, the rise in life expectancy, rising lingering disease are creating demand for innovative drugs.

CORPORATE OFFICE:

Orion Market Research Pvt Ltd
116, Shagun Arcade
Vijay Nagar Square
Indore, Madhya Pradesh – India- 452010
Email: info@omrglobal.com, support@omrglobal.com
India: +91-780-304-0404
Global: +1-646-755-7667

Anurag Tiwari
Orion Market Research Pvt. Ltd.
+919179828694

This release was published on openPR.